SkyView Investment Advisors LLC Purchases 3,000 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)

SkyView Investment Advisors LLC raised its position in MiMedx Group, Inc. (NASDAQ:MDXG) by 30.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,000 shares of the company’s stock after purchasing an additional 3,000 shares during the period. SkyView Investment Advisors LLC’s holdings in MiMedx Group were worth $77,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in MDXG. Barclays PLC boosted its stake in MiMedx Group by 163.9% during the third quarter. Barclays PLC now owns 262,449 shares of the company’s stock valued at $1,550,000 after buying an additional 163,005 shares during the period. Orion Capital Management LLC raised its holdings in shares of MiMedx Group by 46.3% in the 3rd quarter. Orion Capital Management LLC now owns 11,700 shares of the company’s stock valued at $69,000 after acquiring an additional 3,700 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of MiMedx Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 2,794,358 shares of the company’s stock valued at $16,518,000 after acquiring an additional 44,254 shares during the last quarter. Disciplined Growth Investors Inc. MN grew its holdings in shares of MiMedx Group by 0.8% during the third quarter. Disciplined Growth Investors Inc. MN now owns 355,387 shares of the company’s stock worth $2,100,000 after purchasing an additional 2,737 shares in the last quarter. Finally, Jane Street Group LLC increased its position in shares of MiMedx Group by 133.6% in the third quarter. Jane Street Group LLC now owns 305,652 shares of the company’s stock worth $1,806,000 after purchasing an additional 174,797 shares during the last quarter. 79.15% of the stock is currently owned by hedge funds and other institutional investors.

MiMedx Group Stock Performance

NASDAQ:MDXG opened at $9.44 on Friday. The company has a market capitalization of $1.39 billion, a price-to-earnings ratio of 17.16 and a beta of 1.98. The business has a 50 day moving average of $7.58 and a 200 day moving average of $7.01. The company has a debt-to-equity ratio of 0.10, a current ratio of 4.10 and a quick ratio of 3.53. MiMedx Group, Inc. has a 1-year low of $5.47 and a 1-year high of $10.14.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $12.00.

MiMedx Group Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.